Engage Therapeutics, Inc. — Form D
Engage Therapeutics, Inc. of SUMMIT, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2017-10-10. The offering totals $23.6M, of which $23.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-10-10
- Form: D
- Accession: 0001555710-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $23.6M
- Amount sold: $23.6M
- Investors: 16
- Date of first sale: 2017-09-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-296279
Issuer
- Name: Engage Therapeutics, Inc.
- CIK: 0001719075
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 31 LENOX ROAD, SUMMIT, NJ, 07901
- Phone: 215-696-9659
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Gerry D Brunk | Director | Weston, MA |
| Stephen D Collins | Director | Lake Forest, IL |
| Heath D Lukatch | Director | Fort Worth, TX |
| Jouko D Isojarvi | Executive Officer | Durham, NC |
| Orrin Devinsky | Director | New York, NY |
| Stephen Collins | Director | Moraga, CA |
| Gregory Mayes | Director | Morristown, NJ |
| Gregory Mayes | Executive Officer | Morristown, NJ |
| Gregory Mayes | Promoter | Morristown, NJ |
| Mark Theeuwes | Executive Officer | Morristown, NJ |
| Heath Lukatch | Director | Burlingame, CA |
| Gerry Brunk | Director | Ann Arbor, MI |
| Warren Lammert | Director | Seattle, WA |
| Jouko Isojarvi | Executive Officer | Durham, NC |
Other filings by this issuer (1)
More